The U.S. Food and Drug Administration (FDA) Releases Report: National Shortage of Rifapentine Tablets

2019 Annual Tuberculosis Statistics. With World TB Day on March 24, find out the state and national numbers here!

The U.S. Centers for Disease Control and Prevention (CDC) and the National Tuberculosis Controllers Association (NTCA) Release New Guidelines for Treatment of Latent Tuberculosis Infection (LTBI).

FDA has removed Aplisol from its current shortage listing.

The Centers for Disease Control and Prevention (CDC) and the National Tuberculosis Controllers Association (NTCA) have released “Tuberculosis Screening, Testing, and Treatment of U.S. Health-Care Personnel: Recommendations from the National Tuberculosis Controllers Association and CDC, 2019”

Revised 2018 Follow up Worksheet and needs for Ohio Disease Reporting System (ODRS) - Video training with visuals (25:59). Discusses changes to Electronic Disease Notification (EDN) Follow-Up Worksheet and changes in entry into Immigrant Investigation cases in ODRS.

Nationwide Shortage of Tuberculin Skin Test Antigens: CDC Recommendations for Patient Care and Public Health Practice

Ohio's Tuberculosis Data for 2018 is now available.

12/10/2018: The Centers for Disease Control and Prevention (CDC) has learned of an interruption in the supply of cycloserine, which is likely to last for at least the next several weeks.

National TB Controllers Association's (NTCA) new resource for providers regarding the isoniazid-rifapentine (3HP) regimen to Treat latent tuberculosis infection (LTBI) based on the Centers for Disease Control and Prevention's (CDC) recently released guidance.